Diagnostics News and Research

RSS

NeoMed invests in CytoCore

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that NeoMed has made an investment in CytoCore Inc.

11 Mar 2010

Response Biomedical's 2009 total revenues up 69%

Response Biomedical Corporation reported that it recorded total revenues of $9,946,269, an increase of 69% compared to $5,876,337 in 2008. Clinical products revenue for the year ended December 31, 2009 increased 85% to $6,828,651 compared to $3,683,706 in 2008.

11 Mar 2010

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the year was $262 million, up 46% from $179 million in 2008, exceeding the company’s 2009 guidance of $223 million to $243 million, as adjusted to reflect the inclusion of two new partner companies.

11 Mar 2010

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

MRI (magnetic resonance imaging) scans provide extraordinarily clear images of the human body and are commonly used to diagnose a wide range of illnesses and injuries, such as Alzheimer’s disease, cancerous tumors, and torn ligaments. Analog Devices, Inc., the leading provider of data conversion technology and longtime collaborator with the medical imaging industry, today introduced a breakthrough in data conversion that gives clinicians and radiologists the superior image clarity they need to see smaller anatomical structures and abnormalities, such as breast cancer cells, than ever before.

11 Mar 2010

WHO issues new guidelines for malaria treatment

The World Health Organization (WHO) is releasing new guidelines for the treatment of malaria, and the first ever guidance on procuring safe and efficacious anti-malarial medicines.

11 Mar 2010

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

West Coast Neurodiagnostics & MRI, a leading network of top-notch diagnostic centers with board-certified physicians, today announced it has become Coast2Coast Diagnostics (C2C). The name change represents a nationwide expansion of the company’s renowned network and underscores its commitment to being the affordable, efficient choice for specialty medical care delivery.

11 Mar 2010

NHL stars donate funds to BC Children's Hospital

Vancouver Canucks Daniel and Henrik Sedin, together with their wives Marinette and Johanna, have made a gift of $1.5 million to help build a new BC Children's Hospital.

11 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

Eureka Genomics announces closing of $3.7M private financing round

Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics’ high-throughput sequencing and bioinformatics service business on a global basis.

11 Mar 2010

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Cancer diagnostics company Biomoda, Inc. (www.biomoda.com) and Obio, Inc., a corporation formed to pursue public and private funding for cancer research in Ohio, are working together to expand Biomoda’s lung cancer screening program for veterans into Ohio.

10 Mar 2010

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.

10 Mar 2010

TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

Isilon® Systems today announced that The Translational Genomics Research Institute has deployed Isilon scale-out NAS as the primary storage solution powering its next-generation biomedical research. By using Isilon IQ to power multiple genome sequencing devices, TGen has unified its mission-critical operations onto a single, high-performance, highly scalable shared pool of storage, increasing workflow productivity and reducing costs to accelerate the discovery of new treatments for life-threatening diseases.

10 Mar 2010

Integrated public and investor relations healthcare and life sciences practice launched

Feintuch Communications, Inc. (www.feintuchcommunications.com) has created an integrated public and investor relations healthcare and life sciences practice, naming Jules Abraham as vice president of the firm and managing director of the new group.

10 Mar 2010

Imaging tools may help address challenging clinical dilemma of prostate cancer care: Study

New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation's President and CEO Dr. Faina Shtern said today.

10 Mar 2010

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

OVA1™, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc., the world's leading cancer diagnostics provider.

From Quest Diagnostics 10 Mar 2010

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

9 Mar 2010

mtm laboratories launches CINtec PLUS screening system for cervical cancer

mtm laboratories, a privately held diagnostics company today announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm’s nominated distributors.

8 Mar 2010

Chinmax Medical Systems files complaint against Inverness Medical Beijing over distribution rights for Biosite products

On January 28, 2010, Chinmax Medical Systems, Inc., a leading distributor of clinical diagnostics in China, filed a civil complaint in the People's Court of Yangpu District, Shanghai against Inverness Medical Beijing Co. Ltd., a subsidiary of Inverness Medical Innovations, Inc..

8 Mar 2010

Scientists devise software algorithm to detect medically useful information from whole-blood samples

Scientists at the Stanford University School of Medicine have devised a software algorithm that could enable a common laboratory device to virtually separate a whole-blood sample into its different cell types and detect medically important gene-activity changes specific to any one of those cell types.

8 Mar 2010

Roche, OrbiMed, McKinsey announce fifteen finalists of SEED Competition

Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai’s Zhangjiang Hi-Tech Park on March 2, 2010. The event was managed and presented by ChinaBio® Accelerator. The finalists will go on to compete for the grand prize of RMB 300,000 to be presented at the SEED Final Competition and Award Ceremony in Shanghai on April 23, 2010.

6 Mar 2010

Diagnostics News and Research

NeoMed invests in CytoCore

Response Biomedical's 2009 total revenues up 69%

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

WHO issues new guidelines for malaria treatment

West Coast Neurodiagnostics & MRI announces name change to Coast2Coast Diagnostics

NHL stars donate funds to BC Children's Hospital

PBI and TDI announce strategic licensing and collaborative research and development agreement

Eureka Genomics announces closing of $3.7M private financing round

Biomoda, Obio collaborate to expand Biomoda’s lung cancer screening program for veterans into Ohio

Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM

TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

Integrated public and investor relations healthcare and life sciences practice launched

Imaging tools may help address challenging clinical dilemma of prostate cancer care: Study

OVA1 blood test aids in pre-surgical evaluation of women for ovarian cancer now available through Quest Diagnostics

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

mtm laboratories launches CINtec PLUS screening system for cervical cancer

Chinmax Medical Systems files complaint against Inverness Medical Beijing over distribution rights for Biosite products

Scientists devise software algorithm to detect medically useful information from whole-blood samples

Roche, OrbiMed, McKinsey announce fifteen finalists of SEED Competition

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News